Doctor profile · Federal record
Dr. Tina Shah, MD
Rheumatology Physician (CMS: Rheumatology) · Hospitalist Physician · Internal Medicine Physician · Kansas City, MO
- NPI 1972766368
- Accepts Medicare
- MIPS 87.6 / 100 · 2023
- 19 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
4440 Broadway Blvd
Kansas City, MO 641113315
(703) 751-8804
fax (703) 751-1218 - Additional location
-
101 S Whiting St Ste 105
Alexandria, VA 223043416
Credentials & registration
- NPI registered
- July 2008 — 18 yrs on file
- Profile last updated
- March 15, 2021
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- District of Columbia #MD038290 · Virginia #0101247807
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972766368. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
153,565
Distinct HCPCS
10
Medicare allowed
$2,042,204
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 77,600 | 18 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 32,240 | 20 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,025 | 33 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 9,020 | 59 | $33 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 8,250 | 19 | $13 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 5,030 | 17 | $45 | |
J9312 |
Injection, rituximab, 10 mg | 1,820 | 11 | $80 | |
J0897 |
Injection, denosumab, 1 mg | 1,800 | 20 | $23 | |
36415 |
Insertion of needle into vein for collection of blood sample | 702 | 319 | $4 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 694 | 343 | $124 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 3,614. This provider delivers 42× the peer median.Open Payments
Industry payments received
All-time total
$343
Transactions
8
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | 4 | $138.86 | |
| Janssen Biotech, Inc. | 2 | $138.79 | |
| UCB, Inc. | 1 | $35.67 | |
| ABBVIE INC. | 1 | $29.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,546
Patients
820
Total drug cost
$94,257
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 554 | 184 | $46,816 |
| Methotrexate (Methotrexate Sodium) | Brand | 473 | 139 | $22,029 |
| Prednisone | Generic | 420 | 133 | $4,445 |
| Tramadol Hcl | Generic | 252 | 65 | $1,889 |
| Cyclobenzaprine Hcl | Generic | 122 | 47 | $2,074 |
| Allopurinol | Generic | 117 | 30 | $2,196 |
| Sulfasalazine | Generic | 109 | 37 | $3,549 |
| Duloxetine Hcl | Generic | 94 | 40 | $2,725 |
| Folic Acid | Generic | 90 | 34 | $514 |
| Gabapentin | Generic | 82 | 26 | $1,844 |
Hospital affiliations
Frequently asked questions
What is Dr. Tina Shah's medical specialty?
Dr. Tina Shah practices Rheumatology Physician in Kansas City, MO.
Where does Dr. Tina Shah practice?
Dr. Tina Shah practices at 4440 Broadway Blvd, Kansas City, MO 641113315. Office phone: 7037518804.
What is Dr. Tina Shah's NPI?
Dr. Tina Shah's National Provider Identifier (NPI) is 1972766368, issued by NPPES.
Does Dr. Tina Shah accept Medicare assignment?
Yes. Dr. Tina Shah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tina Shah commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.